DJIA 17,342.09 146.67 0.85%
NASDAQ 4,628.03 61.90 1.36%
S&P 500 2,011.75 17.10 0.86%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

163.74 2.16 (1.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $163.62 1.26%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $164.56
Previous Close $161.58
Daily Range $162.84 - $164.65
52-Week Range $108.20 - $164.65
Market Cap $124.6B
P/E Ratio 25.45
Dividend (Yield) $2.44 (1.5%)
Ex-Dividend Date
Dividend Pay Date
11/10/14
12/05/14
Volume 340,517
Average Daily Volume 4,719,439
Current FY EPS $8.24

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary Rss Feed

Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off

Pfizer's third-quarter earnings report points to strength in emerging markets and select segments of its business, but also lends to the reality that a turnaround could be a long time coming.

United Therapeutics Sells Off On Good News - Why I Bought That Dip

3 Stocks Reiterated As A Buy: AIG, GS, AMGN

Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary

Ebola Vaccine Contenders

Amgen Continues To Offer The Best Value In Biotech

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog

Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog

UPDATE: Nomura Upgrades Amgen

Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success

See More AMGN News...

AMGN's Top Competitors

AMGN $163.74 (1.34%)
Current stock: AMGN
GILD $115.86 (1.44%)
Current stock: GILD
CELG $108.49 (1.45%)
Current stock: CELG
$0.00 (0.00%)
Current stock: